ArticleUlusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES2026
Prognostic value of the shock index in Fournier's gangrene: a retrospective cohort study comparing established mortality scoring systems.
Article in Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFournier's gangrene is a rapidly progressive, life-threatening necrotizing infection of the perineal and genital re-gions, associated with persistently high mortality despite advances in surgical and intensive care. Early and reliable prognostic assess-ment is essential for improving patient outcomes. This study aimed to evaluate the prognostic performance of the Shock Index (SI) in predicting mortality in patients with Fournier's gangrene and to compare its discriminatory ability with established scoring systems.
methodsThis retrospective cohort study included adult patients diagnosed with Fournier's gangrene who presented to the emergency department of a tertiary university hospital and underwent surgical debridement between January 2015 and December 2024. Demographic, clinical, and laboratory data were extracted from institutional and national electronic health records. Survivors and non-survivors were compared using appropriate statistical tests. Variables associated with mortality were assessed using logistic regression analysis. Receiver operating characteristic (ROC) analysis was performed to evaluate the predictive performance of SI and conventional scoring systems, and the optimal SI cut-off for mortality prediction was determined using Youden's index.
resultsA total of 158 patients (mean age 62.3±13.4 years; 86.1% male) were included, with an overall mortality rate of 17.1%. Non-survivors were significantly older (p<0.001), and comorbidities including coronary artery disease, chronic heart failure, and chronic renal failure were significantly associated with mortality. At admission, non-survivors had higher heart and respiratory rates and lower systolic blood pressure. ROC analysis demonstrated that the Shock Index had the highest discriminatory performance for mortality prediction (area under the curve=0.952; 95% confidence interval 0.918-0.986; p<0.001), outperforming the Fournier Gan-grene Severity Index, Uludağ Fournier Gangrene Severity Index, Laboratory Risk Indicator for Necrotizing Fasciitis, and quick Sequen-tial Organ Failure Assessment. An optimal SI threshold of 0.866 yielded 92.6% sensitivity and 83.2% specificity.
conclusionThe Shock Index demonstrated superior prognostic accuracy compared with conventional scoring systems in patients with Fournier's gangrene. Given its simplicity and reliance on two readily available hemodynamic parameters, SI represents a practical tool for early risk stratification. Prospective, multicenter studies are needed to further validate its clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.